FiltersReset Filters

With box warnings

Without box warnings

Branded

Generic

4 results

everolimus
(Everolimus)
ENDO USA, Inc.
Usage: Everolimus Tablets are indicated for postmenopausal women with advanced hormone receptor-positive, HER2-negative breast cancer; adults with progressive neuroendocrine tumors (pancreatic, gastrointestinal, or lung origin); advanced renal cell carcinoma after prior treatment failure; renal angiomyolipoma associated with tuberous sclerosis complex; and subependymal giant cell astrocytoma in TSC patients.
everolimus
(Everolimus)
Ascend Laboratories, LLC
Usage: Everolimus tablets are indicated for the prophylaxis of organ rejection in adult kidney transplant patients at low to moderate immunologic risk, in conjunction with basiliximab, cyclosporine, and corticosteroids. They are also used for liver transplant patients starting no sooner than 30 days post-transplant, alongside tacrolimus and corticosteroids.
sirolimus
(sirolimus)
Glenmark Pharmaceuticals Inc., USA
Usage: Sirolimus tablets are indicated for the prophylaxis of organ rejection in renal transplant patients aged 13 and older and for treating lymphangioleiomyomatosis (LAM). In renal transplantation, it is used in combination with cyclosporine and corticosteroids, especially for patients at high immunologic risk.
sirolimus
(Sirolimus)
VistaPharm, LLC
Usage: Sirolimus Oral Solution is indicated for the prophylaxis of organ rejection in renal transplant patients aged 13 and older. It is used with cyclosporine and corticosteroids, particularly in patients at low-to-moderate immunologic risk, with specific combinations recommended for high-immunologic risk patients.

mTOR Inhibitor Immunosuppressant class drugs

everolimus

everolimus

sirolimus

sirolimus